NWHJX
Price
$11.88
Change
-$0.11 (-0.92%)
Updated
Nov 13 closing price
Net Assets
263.48M
VTIAX
Price
$40.28
Change
-$0.40 (-0.98%)
Updated
Nov 13 closing price
Net Assets
554.27B
Interact to see
Advertisement

NWHJX vs VTIAX

Header iconNWHJX vs VTIAX Comparison
Open Charts NWHJX vs VTIAXBanner chart's image
Nationwide Bailard Intl Eqs A
Price$11.88
Change-$0.11 (-0.92%)
VolumeN/A
Net Assets263.48M
Vanguard Total Intl Stock Index Admiral
Price$40.28
Change-$0.40 (-0.98%)
VolumeN/A
Net Assets554.27B
NWHJX vs VTIAX Comparison Chart in %
View a ticker or compare two or three
VS
NWHJX vs. VTIAX commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NWHJX is a Hold and VTIAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VTIAX has more cash in the bank: 554B vs. NWHJX (263M). NWHJX (2.79) and VTIAX (2.70) have matching dividends . NWHJX was incepted earlier than VTIAX: NWHJX (20 years) vs VTIAX (15 years). NWHJX (1.20) is less costly to investors than VTIAX (0.09). NWHJX is a more actively managed with annual turnover of: 38.37 vs. VTIAX (3.00). NWHJX has a lower initial minimum investment than VTIAX: NWHJX (2000) vs VTIAX (3000). NWHJX annual gain was more profitable for investors over the last year : 30.30 vs. VTIAX (25.12). NWHJX return over 5 years is better than : 68.97 vs. VTIAX (39.59).
NWHJXVTIAXNWHJX / VTIAX
Total Expense Ratio1.200.091,333%
Annual Report Gross Expense Ratio1.200.091,333%
Fund Existence20 years15 years-
Gain YTD32.05528.912111%
Front Load6%N/A-
Min. Initial Investment2000300067%
Min. Initial Investment IRAN/AN/A-
Net Assets263M554B0%
Annual Yield % from dividends2.792.70103%
Returns for 1 year30.3025.12121%
Returns for 3 years74.9249.28152%
Returns for 5 years68.9739.59174%
Returns for 10 years93.8179.35118%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ACRV2.280.21
+10.14%
Acrivon Therapeutics
MRNA26.710.30
+1.14%
Moderna
EGHAU10.55N/A
N/A
EGH Acquisition Corp.
RAMP30.46-0.42
-1.36%
LiveRamp Holdings
IMRX6.62-0.12
-1.78%
Immuneering Corp